Browsing Category


1 post

Co-Diagnostics Inc. CODX (NASDAQ) is a small biotech company that develops molecular diagnostic tests. Its tests are used to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue, and HIV. The company mostly capitalized on the coronavirus pandemic with its in vitro diagnostic test that uses patented CoPrimer™ technology. Get extensive Co-diagnostics Inc. stock news, analysis, research, and forecast here.